Trade Summary
1 month ago, Ra Capital Management, L.P., serving as 10% owner at Adicet Bio, Inc. (ACET), purchased 223,596 shares at $7.17 per share, for a total transaction value of $1,603,934.00. Following this transaction, Ra Capital Management, L.P. now holds 1,182,624 shares of ACET.
This purchase represents a 23.00% increase in Ra Capital Management, L.P.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.
The trade was executed on Wednesday, February 18, 2026 and publicly disclosed via SEC Form 4 filing on Monday, April 13, 2026, 54 days after the trade was made.
Adicet Bio, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.
